Shareholders' Equity (Tables)

6 Months Ended

Jun. 30, 2014

Equity [Abstract]

Share-Based Activity

Other information pertaining to share-based activity during the three and six months ended June 30, 2014and 2013 was as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2014		2013		2014		2013
Share-based compensation expense	$	2,506	$	1,916	$	4,964	$	3,966
Fair value of shares vested	1,183		1,318		10,358		10,500
Cash received from option exercises	1,158		8,037		1,646		13,728
Tax benefit from option exercises	363		922		2,090		1,210

Schedule Of Changes In Non-Vested Restricted Shares

A summary of the status of non-vested restricted shares at June 30, 2014 and changes during the six months ended June 30, 2014 is as follows:

			Weighted
	Number		Average
	of Shares		Grant Price
Non-vested shares at December 31, 2013	743,869		$	26.54
Shares granted	225,521		42.25
Shares vested	(247,128	)	23.30
Shares forfeited	(7,129	)	32.81
Non-vested shares at June 30, 2014	715,133		$	32.55

Schedule Of Stock Option Activity

A summary of stock option activity for the six months ended June 30, 2014 is summarized as follows:

					Weighted
			Weighted		Average
			Average		Remaining
	Number		Exercise		Contractual
	of Shares		Price		Term (in years)
Outstanding at December 31, 2013	270,464		$	23.16	2.5
Options exercised with total intrinsic value of $1,649,000	(68,868	)	23.90
Outstanding at June 30, 2014 with an aggregate intrinsic value of $4,569,000	201,596		$	22.90	2.2
Vested at June 30, 2014 with an aggregate intrinsic value of $4,569,000	201,596		$	22.90	2.2
Exercisable at June 30, 2014 with an aggregate intrinsic value of $4,569,000	201,596		$	22.90	2.2

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

The following is a reconciliation of the numerator and denominators of basic and diluted earnings per share (in thousands, except per share amounts):

	Three Months Ended June 30,					Six Months Ended June 30,
	Earnings		Shares	Per Share		Earnings		Shares	Per Share
	(Numerator)		(Denominator)	Amount		(Numerator)		(Denominator)	Amount
2014:
Net earnings from continuing operations attributable to AmSurg Corp. per common share (basic)	$	18,954	31,825	$	0.60	$	36,458	31,770	$	1.15
Effect of dilutive securities options and non-vested shares	—		408			—		407
Net earnings from continuing operations attributable to AmSurg Corp. per common share (diluted)	$	18,954	32,233	$	0.59	$	36,458	32,177	$	1.13
Net earnings attributable to AmSurg Corp. per common share (basic)	$	18,961	31,825	$	0.60	$	36,156	31,770	$	1.14
Effect of dilutive securities options and non-vested shares	—		408			—		407
Net earnings attributable to AmSurg Corp. per common share (diluted)	$	18,961	32,233	$	0.59	$	36,156	32,177	$	1.12
2013:
Net earnings from continuing operations attributable to AmSurg Corp. per common share (basic)	$	18,417	31,208	$	0.59	$	36,167	31,213	$	1.16
Effect of dilutive securities options and non-vested shares	—		654			—		659
Net earnings from continuing operations attributable to AmSurg Corp. per common share (diluted)	$	18,417	31,862	$	0.58	$	36,167	31,872	$	1.13
Net earnings attributable to AmSurg Corp. per common share (basic)	$	18,563	31,208	$	0.59	$	36,374	31,213	$	1.17
Effect of dilutive securities options and non-vested shares	—		654			—		659
Net earnings attributable to AmSurg Corp. per common share (diluted)	$	18,563	31,862	$	0.58	$	36,374	31,872	$	1.14